EP4238104A1 - Système de surveillance de patient pour détecter des données d'un patient, dispositif d'affichage, dispositif de traitement médical et procédé - Google Patents
Système de surveillance de patient pour détecter des données d'un patient, dispositif d'affichage, dispositif de traitement médical et procédéInfo
- Publication number
- EP4238104A1 EP4238104A1 EP21805405.4A EP21805405A EP4238104A1 EP 4238104 A1 EP4238104 A1 EP 4238104A1 EP 21805405 A EP21805405 A EP 21805405A EP 4238104 A1 EP4238104 A1 EP 4238104A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- patient
- data
- vital parameters
- behavior
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000011282 treatment Methods 0.000 title claims abstract description 181
- 238000012544 monitoring process Methods 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 title claims description 20
- 230000009471 action Effects 0.000 claims abstract description 26
- 238000001514 detection method Methods 0.000 claims abstract description 21
- 239000008280 blood Substances 0.000 claims description 69
- 210000004369 blood Anatomy 0.000 claims description 69
- 230000006399 behavior Effects 0.000 claims description 58
- 230000001105 regulatory effect Effects 0.000 claims description 17
- 238000000502 dialysis Methods 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 13
- 238000012545 processing Methods 0.000 claims description 13
- 230000003542 behavioural effect Effects 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 11
- 238000004891 communication Methods 0.000 claims description 10
- 230000033001 locomotion Effects 0.000 claims description 8
- 230000036772 blood pressure Effects 0.000 claims description 6
- 238000001631 haemodialysis Methods 0.000 claims description 6
- 230000000322 hemodialysis Effects 0.000 claims description 6
- 208000037921 secondary disease Diseases 0.000 claims description 6
- 230000002526 effect on cardiovascular system Effects 0.000 claims description 5
- 230000036760 body temperature Effects 0.000 claims description 4
- 230000001276 controlling effect Effects 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 238000002615 hemofiltration Methods 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 230000036387 respiratory rate Effects 0.000 claims description 3
- 238000002617 apheresis Methods 0.000 claims description 2
- 230000001684 chronic effect Effects 0.000 claims description 2
- 238000002616 plasmapheresis Methods 0.000 claims description 2
- 238000012959 renal replacement therapy Methods 0.000 claims description 2
- 230000000241 respiratory effect Effects 0.000 claims description 2
- 238000001179 sorption measurement Methods 0.000 claims description 2
- 239000000385 dialysis solution Substances 0.000 description 16
- 238000007405 data analysis Methods 0.000 description 8
- 239000012141 concentrate Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 239000012528 membrane Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000000108 ultra-filtration Methods 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 102000005393 Sodium-Potassium-Exchanging ATPase Human genes 0.000 description 3
- 108010006431 Sodium-Potassium-Exchanging ATPase Proteins 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 230000004872 arterial blood pressure Effects 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 101100284769 Drosophila melanogaster hemo gene Proteins 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000002682 Hyperkalemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000011022 operating instruction Methods 0.000 description 1
- 230000001698 pyrogenic effect Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
- A61M1/3424—Substitution fluid path
- A61M1/3431—Substitution fluid path upstream of the filter
- A61M1/3434—Substitution fluid path upstream of the filter with pre-dilution and post-dilution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3496—Plasmapheresis; Leucopheresis; Lymphopheresis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3622—Extra-corporeal blood circuits with a cassette forming partially or totally the blood circuit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3317—Electromagnetic, inductive or dielectric measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Definitions
- the computing unit is further programmed to generate
- Pairing is a process that occurs in the context of computer networks to establish an initial association between computing devices for the purpose of communication.
- the most well-known example of this is the establishment of a Bluetooth connection, which is used to connect different devices (e.g. smartphone, headphones) with one another. Pairing is also sometimes referred to as bonding.
- the object according to the invention has one or more features in a specific embodiment, it is also disclosed here in each case that the object according to the invention expressly does not have this or these features in other embodiments that are also according to the invention has e.g. B. as a disclaimer. It is therefore true for each embodiment mentioned herein that the opposite embodiment, formulated as a negation, for example, is also disclosed.
- the vital parameters are or include heart rate, respiratory rate, blood pressure and/or body temperature. In some embodiments, the vital parameters also include oxygen saturation.
- the result of this comparison is evaluated using a value range and/or at least one limit value.
- Embodiments using a patient monitor system according to the invention Embodiments using a patient monitor system according to the invention.
- FIG. 1 shows a mixing device 163 which provides a predetermined mixture for the respective solution for use by the treatment device 100 from the containers A (for A concentrate via the concentrate supply 166 ) and B (for B concentrate via the concentrate supply 168 ).
- the solution contains e.g. B. water heated by means of a heat exchanger 157 (online, e.g. as reverse osmosis water or from bags) from the water source 155 .
- a drain line 153 for the Ef fluent can be seen.
- the optional heat exchanger 157 and a first pump or flow pump 159 suitable for degassing complement the arrangement shown.
- the treatment device 100 optionally includes a device 161 for balancing the flow flowing into and out of the dialyzer 303 on the machine side.
- the device 161 for balancing is preferably arranged in a line area between the first flow pump 159 and the second flow pump 169 .
- the filter Fl is used here, for example, to produce sufficiently pure dialysis liquid by means of the mixing device 163 itself using impure water, which then, e.g. B. in the countercurrent principle, flows through the blood filter 303 .
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Anesthesiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Data Mining & Analysis (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Databases & Information Systems (AREA)
- Pathology (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- External Artificial Organs (AREA)
Abstract
La présente invention concerne un système de surveillance de patient (1), comprenant au moins un dispositif de détection (3) qui est programmé pour détecter des données relatives au comportement et/ou des paramètres vitaux d'un patient. Le système de surveillance de patient (1) comprend en outre un dispositif de sortie (7) et une unité de calcul (9). L'unité de calcul (9) est programmée pour amener le dispositif de détection (3) à détecter les données et les paramètres vitaux. Ladite unité de calcul est en outre programmée pour générer des instructions d'action pour la commande en boucle ouverte ou en boucle fermée d'un dispositif de traitement médical (100) et pour délivrer les instructions d'action au moyen du dispositif de sortie (7). L'unité de calcul (9) est en outre programmée pour générer des instructions d'action et/ou pour avoir ces instructions d'action délivrées au moyen du dispositif de sortie (7) lorsqu'au moins les données relatives au comportement du patient ou certaines de ces données et les paramètres vitaux du patient ou certains de ces paramètres vitaux ne se trouvent pas dans une plage de valeurs (W) qui est prédéterminée pour eux dans chaque cas et/ou se trouvent au-delà d'une valeur limite (L) qui est prédéterminée pour eux dans chaque cas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102020128298.2A DE102020128298A1 (de) | 2020-10-28 | 2020-10-28 | Patientenmonitorsystem zum Erfassen von Daten eines Patienten, Anzeigevorrichtung, medizinische Behandlungsvorrichtung und Verfahren |
| PCT/EP2021/079830 WO2022090314A1 (fr) | 2020-10-28 | 2021-10-27 | Système de surveillance de patient pour détecter des données d'un patient, dispositif d'affichage, dispositif de traitement médical et procédé |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4238104A1 true EP4238104A1 (fr) | 2023-09-06 |
Family
ID=78536166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP21805405.4A Pending EP4238104A1 (fr) | 2020-10-28 | 2021-10-27 | Système de surveillance de patient pour détecter des données d'un patient, dispositif d'affichage, dispositif de traitement médical et procédé |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230395252A1 (fr) |
| EP (1) | EP4238104A1 (fr) |
| DE (1) | DE102020128298A1 (fr) |
| WO (1) | WO2022090314A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117133463B (zh) * | 2023-10-24 | 2023-12-22 | 中国人民解放军总医院第二医学中心 | 一种血液透析容量负荷多维评估系统 |
| CN117524444B (zh) * | 2024-01-05 | 2024-03-12 | 遂宁市中心医院 | 一种基于数据分析的麻醉药剂存储环境监控管理系统 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7860583B2 (en) | 2004-08-25 | 2010-12-28 | Carefusion 303, Inc. | System and method for dynamically adjusting patient therapy |
| US8246563B2 (en) * | 2006-02-02 | 2012-08-21 | Cardiac Pacemakers, Inc. | Cardiac rhythm management device and sensor-suite for the optimal control of ultrafiltration and renal replacement therapies |
| US8057679B2 (en) * | 2008-07-09 | 2011-11-15 | Baxter International Inc. | Dialysis system having trending and alert generation |
| US8239010B2 (en) | 2009-09-14 | 2012-08-07 | Sotera Wireless, Inc. | System for measuring vital signs during hemodialysis |
| US9848778B2 (en) * | 2011-04-29 | 2017-12-26 | Medtronic, Inc. | Method and device to monitor patients with kidney disease |
| US8926542B2 (en) | 2011-04-29 | 2015-01-06 | Medtronic, Inc. | Monitoring fluid volume for patients with renal disease |
| US10595775B2 (en) * | 2013-11-27 | 2020-03-24 | Medtronic, Inc. | Precision dialysis monitoring and synchronization system |
-
2020
- 2020-10-28 DE DE102020128298.2A patent/DE102020128298A1/de active Pending
-
2021
- 2021-10-27 US US18/033,883 patent/US20230395252A1/en active Pending
- 2021-10-27 WO PCT/EP2021/079830 patent/WO2022090314A1/fr unknown
- 2021-10-27 EP EP21805405.4A patent/EP4238104A1/fr active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE102020128298A1 (de) | 2022-04-28 |
| WO2022090314A1 (fr) | 2022-05-05 |
| US20230395252A1 (en) | 2023-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2996737B1 (fr) | Dispositif et procédé de chargement de paramètres de traitement d'un patient | |
| DE60205433T2 (de) | Vorrichtung und Verfahren zur Auswertung der medizinischen Einrichtungen | |
| DE3636995C2 (fr) | ||
| JP4276834B2 (ja) | 生体情報及び血液処理装置情報管理システム | |
| DE102016001710B4 (de) | Gerät zur extrakorporalen Blutbehandlung mit einer Auswerte- und Steuereinheit | |
| WO2022090314A1 (fr) | Système de surveillance de patient pour détecter des données d'un patient, dispositif d'affichage, dispositif de traitement médical et procédé | |
| EP2850547B1 (fr) | Dispositif et méthode pour l'adoption d'une valeur standard proposée dans le dispositif de contrôle d'un appareil médical | |
| DE102012021805A1 (de) | Vorrichtung und Verfahren zur Überwachung der Behandlung eines Patienten | |
| DE102017130548A1 (de) | Verfahren und Vorrichtungen zum Festlegen eines Behandlungsregimes zum Verändern von Behandlungsparametern beim Dialysieren eines Patienten | |
| DE102019128847A1 (de) | System zur Durchführung einer Dialysebehandlung | |
| EP2621550B1 (fr) | Profilage de dialysat commandé par contrôle uv | |
| WO2022180086A1 (fr) | Procédé d'analyse d'une valeur de pression mesurée, et dispositifs | |
| CN110730989B (zh) | 个性化肾衰竭慢性护理系统和方法 | |
| DE102010056605A1 (de) | Computerbasiertes Dialoggerät zur medizinischen Überwachung des Dialysevorgangs | |
| DE102015012519A1 (de) | Bestimmung in Blut gelöster Gase im extrakorporalen Kreislauf | |
| DE102021103209A1 (de) | Gefäßanalysegestütztes medizinisches System zum Festlegen von Einstellwerten einer Blutbehandlungsvorrichtung | |
| DE102020102471A1 (de) | Verfahren und Vorrichtungen zum Festlegen eines Zeitpunkts zum Erheben von Druckmesswerten | |
| EP3193962A1 (fr) | Procédé et dispositif de prévision d'un ou de plusieurs paramètres caractéristiques du résultat d'un traitement sanguin | |
| EP3795191B1 (fr) | Dispositif de traitement du sang à réduction automatique d'un débit de solution de substitution | |
| EP3797805B1 (fr) | Dispositif de traitement du sang à élimination automatique de l'air | |
| WO2023110986A1 (fr) | Dispositif de traitement du sang avec commande de chauffage | |
| DE102019115553A1 (de) | Berechnungsvorrichtung und Dialysevorrichtung | |
| WO2023099545A1 (fr) | Appareil pour contrôler la composition corporelle au moyen d'une électrode tenue en main | |
| DE102021132723A1 (de) | Blutbehandlungsvorrichtung mit gekoppelter Blutpumpe und Drucklufteinrichtung | |
| DE102020110112A1 (de) | Medizinisches Set für Kanülierung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20230530 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) |